Literature DB >> 20832227

Paradoxical high signal intensity of hepatocellular carcinoma in the hepatobiliary phase of Gd-EOB-DTPA enhanced MRI: initial experience.

Seun Ah Lee1, Chang Hee Lee, Woon Yong Jung, Jongmee Lee, Jae Woong Choi, Kyeong Ah Kim, Cheol Min Park.   

Abstract

PURPOSE: To describe the paradoxical high signal intensity of hepatocellular carcinoma (HCC) in the hepatobiliary phase on gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI).
MATERIALS AND METHODS: A database search was performed to identify cases of HCC that showed unusual prolonged enhancement in the hepatobiliary phase of Gd-EOB-DTPA MRI. All patients received 3.0-T liver MRI including precontrast T1-weighted images, T2-weighted images and a post Gd-EOB-DTPA-enhanced dynamic study. The signal intensity of HCC was measured at pre-enhanced, arterial, portal, delayed and hepatobiliary phase using regions of interest. Radiologic and pathologic correlation was performed for the paradoxically prolonged enhancing portion of HCC in the hepatobiliary phase.
RESULTS: Four patients (all male, age range 44-70; mean 57.5 years) were included in this study. All patients showed HCC lesions that were low signal intensity (SI) on T1-WI, high SI on T2-WI, enhanced in arterial phase, and washed-out in delayed phase. All cases showed paradoxically high SI in hepatobiliary phase, which was unusual for HCC. Pathologically, they were all diagnosed as well-differentiated HCC with prominent cytoplasm and a bile secreting appearance.
CONCLUSION: HCC may demonstrate the prolonged high signal intensity at the hepatobiliary phase on Gd-EOB-DTPA enhanced MRI. These HCCs tended to be highly differentiated and to have prominent bile secretion. Crown
Copyright © 2011. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20832227     DOI: 10.1016/j.mri.2010.07.019

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  18 in total

Review 1.  Solid liver masses: approach to management from the standpoint of a radiologist.

Authors:  Robert Garrett
Journal:  Curr Gastroenterol Rep       Date:  2013-12

Review 2.  Differentiation of hepatocellular carcinoma from its various mimickers in liver magnetic resonance imaging: What are the tips when using hepatocyte-specific agents?

Authors:  Yang Shin Park; Chang Hee Lee; Jeong Woo Kim; Sora Shin; Cheol Min Park
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 3.  Advances in computed tomography and magnetic resonance imaging of hepatocellular carcinoma.

Authors:  Tiffany Hennedige; Sudhakar K Venkatesh
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 4.  Benign focal liver lesions masquerading as primary liver cancers on MRI.

Authors:  Manickam Subramanian; Hsien Min Low; Myeong-Jin Kim; Cher Heng Tan
Journal:  Diagn Interv Radiol       Date:  2020-05       Impact factor: 2.630

Review 5.  Recent Advances in Tumor Ablation for Hepatocellular Carcinoma.

Authors:  Tae Wook Kang; Hyunchul Rhim
Journal:  Liver Cancer       Date:  2015-07-17       Impact factor: 11.740

6.  Liver-specific contrast agents.

Authors:  Dow-Mu Koh
Journal:  Cancer Imaging       Date:  2012-09-28       Impact factor: 3.909

7.  Comparison of Sonazoid contrast-enhanced ultrasound and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid MRI for the histological diagnosis of hepatocellular carcinoma.

Authors:  Feiqian Wang; Kazushi Numata; Masahiro Okada; Makoto Chuma; Hiromi Nihonmatsu; Satoshi Moriya; Akito Nozaki; Katsuaki Ogushi; Wen Luo; Litao Ruan; Masayuki Nakano; Masako Otani; Yoshiaki Inayama; Shin Maeda
Journal:  Quant Imaging Med Surg       Date:  2021-06

8.  Hepatocellular carcinoma composed of two different histologic types: imaging features on gadoxetic acid-enhanced liver MRI.

Authors:  Seung Hyun Kim; Woo Kyoung Jeong; Yongsoo Kim; Min Yeong Kim; Jinoo Kim; Ju Yeon Pyo; Young Ha Oh
Journal:  Clin Mol Hepatol       Date:  2013-03

Review 9.  Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring.

Authors:  Tiffany Hennedige; Sudhakar Kundapur Venkatesh
Journal:  Cancer Imaging       Date:  2013-02-08       Impact factor: 3.909

10.  Hepatic angiomyolipoma with special attention to radiologic imaging.

Authors:  Kunitaka Kuramoto; Toru Beppu; Tomohiro Namimoto; Hiromitsu Hayashi; Katsunori Imai; Hidetoshi Nitta; Daisuke Hashimoto; Akira Chikamoto; Takatoshi Ishiko; Ken-Ichi Iyama; Osamu Ikeda; Yasuyuki Yamashita; Hideo Baba
Journal:  Surg Case Rep       Date:  2015-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.